Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
12-month follow-up after successful infliximab therapy in pediatric crohn disease.
Wynands J, Belbouab R, Candon S, Talbotec C, Mougenot JF, Chatenoud L, Schmitz J, Cézard JP, Goulet O, Hugot JP, Ruemmele FM. Wynands J, et al. Among authors: cezard jp. J Pediatr Gastroenterol Nutr. 2008 Mar;46(3):293-8. doi: 10.1097/MPG.0b013e31815604cd. J Pediatr Gastroenterol Nutr. 2008. PMID: 18376247
[New therapeutic approaches in Crohn's disease].
Cézard JP, Hugot JP. Cézard JP, et al. Arch Pediatr. 2001 May;8 Suppl 2:406s-408s. doi: 10.1016/s0929-693x(01)80091-9. Arch Pediatr. 2001. PMID: 11394133 French. No abstract available.
Growth in paediatric Crohn's disease.
Cezard JP, Touati G, Alberti C, Hugot JP, Brinon C, Czernichow P. Cezard JP, et al. Horm Res. 2002;58 Suppl 1:11-5. doi: 10.1159/000064759. Horm Res. 2002. PMID: 12373007 Review.
Crohn's disease: the cold chain hypothesis.
Hugot JP, Alberti C, Berrebi D, Bingen E, Cézard JP. Hugot JP, et al. Among authors: cezard jp. Lancet. 2003 Dec 13;362(9400):2012-5. doi: 10.1016/S0140-6736(03)15024-6. Lancet. 2003. PMID: 14683664 Review.
Efficacy and tolerance of infliximab in children and adolescents with Crohn's disease.
Lamireau T, Cézard JP, Dabadie A, Goulet O, Lachaux A, Turck D, Maurage C, Morali A, Sokal E, Belli D, Stoller J, Cadranel S, Ginies JL, Viola S, Huet F, Languepin J, Lenaerts C, Bury F, Sarles J; French-Speaking Group for Pediatric Gastroenterology Nutrition. Lamireau T, et al. Among authors: cezard jp. Inflamm Bowel Dis. 2004 Nov;10(6):745-50. doi: 10.1097/00054725-200411000-00008. Inflamm Bowel Dis. 2004. PMID: 15626892
Ileal involvement is age dependent in pediatric Crohn's disease.
Meinzer U, Ideström M, Alberti C, Peuchmaur M, Belarbi N, Bellaïche M, Mougenot JF, Cézard JP, Finkel Y, Hugot JP. Meinzer U, et al. Among authors: cezard jp. Inflamm Bowel Dis. 2005 Jul;11(7):639-44. doi: 10.1097/01.mib.0000165114.10687.bf. Inflamm Bowel Dis. 2005. PMID: 15973117
Efficacy of infliximab in pediatric Crohn's disease: a randomized multicenter open-label trial comparing scheduled to on demand maintenance therapy.
Ruemmele FM, Lachaux A, Cézard JP, Morali A, Maurage C, Giniès JL, Viola S, Goulet O, Lamireau T, Scaillon M, Breton A, Sarles J; Groupe Francophone d'Hépatologie, Gastroentérologie et Nutrition Pédiatrique. Ruemmele FM, et al. Among authors: cezard jp. Inflamm Bowel Dis. 2009 Mar;15(3):388-94. doi: 10.1002/ibd.20788. Inflamm Bowel Dis. 2009. PMID: 19023899 Clinical Trial.
159 results